ABSTRACT
submitted to a restricted diet consisting of one-third the average daily intake for rats. hCG intrarectal. hCG administration significantly decreased blood sugar and leptin levels, 39 whereas adiponectins were only relatively sensitive to hCG treatment.
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INTRODUCTION
42
Human chorionic gonadotropin (hCG) was discovered in 1927 by Ascheim and Zondek 43 in the urine of pregnant women and was used for the treatment of conditions such as 44 infertility, cryptorchidism, and obesity [1] [2] [3] . Several extragonadal therapeutic actions have 45 been attributed to hCG, including (but not limited to) Kaposi sarcoma, glaucoma and
46
BPH (Benign Prostatic hypertrophy). One of the most controversial indications was its
47
use in the management of obesity, until a series of double blind studies conducted in 48 humans concluded that weight loss under hCG was no better than placebo. The standard 49 administration route was intramuscular. Its efficacy in obesity treatment was debated for 50 years until some studies found it was not useful for treating this condition [4] [5] [6] [7] [8] . In 1987,
51
Vogt and Belluscio published a study concluding the hCG protocol originally designed .
60
Leptin was discovered in rats in 1994. Subsequently, the human Ob gene was located on 61 chromosome 7. It is a cytokine that plays a key role in the regulation of energy balance. (formaldehyde 5%) and testicles (5% formalin).
142
Statistical methodology
143
The effects of hCG treatment were evaluated using analysis of variance (ANOVA). The Kolmogorov-Smirnov test was also used to assess normality of distributions. 
RESULTS
151
We compared basal and final determinations as follows. diets. No significant differences were found between groups: leptin (Fig. 1A) , p=0.056; 157 glycemia (Fig. 1B) , p=0.291; adiponectin (Fig. 1C) , p=0.364; and fatty acids (Fig. 1D) (Fig. 2D ), but statistically significant differences were observed in 163 leptin (F=7,066, p<0.001) ( Fig. 2A) and glucose (F=3,012, p=0.018) (Fig. 2B) . 
Formulation effect
292
To assess the effect of the administered formulation, groups were analyzed as follows: In addition, significant differences were also observed in mean blood glucose results. The 
